期刊文献+

GnRH激动剂黄体期长方案的优势与不足 被引量:4

Advantages and disadvantages of GnRH agonist long protocol in luteal phase
下载PDF
导出
摘要 促性腺激素释放激素激动剂(GnRH-a)黄体期长方案是目前国内常用的经典方案,该方案在获卵数、优质胚胎数以及子宫内膜容受性方面具有优势,但该方案仍有一些不足,包括导致卵巢过度刺激综合征(OHSS)的发生率增加、促性腺激素(Gn)用量及用时增加、卵巢囊肿形成以及历时较长、患者生活质量报告下降等。但根据其治疗效果,该方案对多数人群友好,可以获得良好的妊娠结局,仍可作为目前主流的治疗方案进行推广。 GnRH agonist long protocol in luteal phase is a classic protocol commonly used in China at present.The protocol has advantages in the number of oocytes retrieved,the number of high quality embryos,and the endometrial receptivity.However,the short comings of the protocol including increased incidence of ovarian hyperstimulation syndrome(OHSS),more gonadotropin dosage used,the formation of ovarian cyst and longer duration,decreasing life quality of patients,etc.According to the treatment outcomes,this protocol is friendly to most of patients and can achieve a satisfying pregnancy outcome.Thus this protocol is still can be chosen as the first line controlled ovarian stimulation protocol for clinicians.
作者 马媛 王晓红 MA Yuan;WANG Xiao-hong(Reproductive Medicine Center,Department of Obstetrics & Gynecology,Tangdu Hospital of Air Force Medical University,Xi’an710038)
出处 《生殖医学杂志》 CAS 2019年第10期1115-1119,共5页 Journal of Reproductive Medicine
基金 国家自然科学基金面上项目(81671463) 陕西省重点研发计划(重点产业创新链)(2017ZDCXL-SF-02-03)
  • 相关文献

参考文献8

二级参考文献105

  • 1张学红,李丽斐,赵丽辉,石馨,贾学玲.应用不同剂量长效GnRHa(达菲林)降调节的临床效果分析[J].生殖与避孕,2005,25(7):435-437. 被引量:27
  • 2魏志新,张丽珠,李美芝,杨池荪,秦莉,刘平,王振红,赵一鸣.卵巢基础状态对促超排卵结局的预测[J].中华妇产科杂志,1997,32(1):27-30. 被引量:19
  • 3Baerwald AR,Adams GP, Pierson RA. Form and function of the corpus luteum during the human menstrual cycle I-J3. Ultrasound Obstet Gynecol[J] 2005,25 : 498-507.
  • 4Metallinou C, Asmakopoulos B, Schroer A, et al. Gonadotropin releasing hormone in the ovary[J]. Reprod Sci, 2007,14 : 737-749.
  • 5Jenkins JM,Anthony FW,Wood P,et al. The development of functional ovarian cyst during pituitary downregulation[J] Hum Reprod, 1993,8:1623-1627.
  • 6Qublan HS, Amarin Z, Tahat YA, et al. Ovarian cyst formation following GnRH agonist administration in IVF cycles:incidence and impact [J]. Hum Reprod, 2006, 21: 640-644.
  • 7Keltz MD,Jones EE, Duleba AJ, et al. Baseline cyst formation after luteal phase gonadotropin releasing hormone agonist administration is linked to poor in vitro fertilization outcome [J]. Fertil Steril, 1995,64 : 568-572.
  • 8Owj M, Ashrafi M, Baghestani AR. Ovarian cyst formation and in vitro fertilization outcome[J]. Int J Obstet Gynecol, 2004.87:258 259.
  • 9Ben-Rafael Z,Bider D, Menash Y, et al. Follicular and luteal cysts after treatment with gonadotropin-releasing hormone analog for in vitro fertilization[J]. Fertil Steril, 1990, 53: 1091 1094.
  • 10Zeyneloglu HB, Isik AZ, Kara S, et al. Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization [J ]. Int J Fertil Womens Med,1998,43:300-305.

共引文献146

同被引文献48

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部